The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dang, O.
Right arrow Articles by David, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dang, O.
Right arrow Articles by David, M.
The Journal of Immunology, 2004, 172: 747-751.
Copyright © 2004 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Anthrax Lethal Toxin Inhibits Activation of IFN-Regulatory Factor 3 by Lipopolysaccharide 1

Oanh Dang, Lorena Navarro, Keith Anderson and Michael David2

Division of Biological Sciences and University of California San Diego Cancer Center, University of California San Diego, La Jolla, CA 92093

IFN-regulatory factor 3 (IRF3) is known to participate in the transcriptional induction of chemokines and cytokines, including IFNs, as a result of viral or bacterial infection. In this study, we demonstrate that the LPS-mediated activation of IRF3 and subsequent induction of chemokine genes or IRF3-responsive reporter constructs are inhibited after exposure of human or murine macrophages to the Bacillus anthracis toxin lethal factor. The inhibitory effect is caused by interference with the activation of the stress-activated protein kinase, p38, due to a proteolytic cleavage of mitogen-activated protein kinase kinase 6, and can be overcome by the ectopic expression of a cleavage-resistant mutant of mitogen-activated protein kinase kinase 6 or a constitutively active IRF3. The lethal factor-mediated inhibition of IRF3 activation and subsequent cytokine production through bacterial membrane components offers Bacillus anthracis an efficient mechanism to evade the innate immune response.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
E. T. Harvill, M. Osorio, C. L. Loving, G. M. Lee, V. K. Kelly, and T. J. Merkel
Anamnestic Protective Immunity to Bacillus anthracis Is Antibody Mediated but Independent of Complement and Fc Receptors
Infect. Immun., May 1, 2008; 76(5): 2177 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Sherer, Y. Li, X. Cui, and P. Q. Eichacker
Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 211 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Chiang, O. Dang, K. Anderson, A. Matsuzawa, H. Ichijo, and M. David
Cutting Edge: Apoptosis-Regulating Signal Kinase 1 Is Required for Reactive Oxygen Species-Mediated Activation of IFN Regulatory Factor 3 by Lipopolysaccharide
J. Immunol., May 15, 2006; 176(10): 5720 - 5724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Yasutomi, Y. Ohshima, N. Omata, A. Yamada, H. Iwasaki, Y. Urasaki, and M. Mayumi
Erythromycin Differentially Inhibits Lipopolysaccharide- or Poly(I:C)-Induced but Not Peptidoglycan-Induced Activation of Human Monocyte-Derived Dendritic Cells
J. Immunol., December 15, 2005; 175(12): 8069 - 8076.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. E. Comer, A. K. Chopra, J. W. Peterson, and R. Konig
Direct Inhibition of T-Lymphocyte Activation by Anthrax Toxins In Vivo
Infect. Immun., December 1, 2005; 73(12): 8275 - 8281.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N.-K. Lim, J.-H. Kim, M. S. Oh, S. Lee, S.-Y. Kim, K.-S. Kim, H.-j. Kang, H. J. Hong, and K.-S. Inn
An Anthrax Lethal Factor-Neutralizing Monoclonal Antibody Protects Rats before and after Challenge with Anthrax Toxin
Infect. Immun., October 1, 2005; 73(10): 6547 - 6551.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-N. Tournier, A. Quesnel-Hellmann, J. Mathieu, C. Montecucco, W.-J. Tang, M. Mock, D. R. Vidal, and P. L. Goossens
Anthrax Edema Toxin Cooperates with Lethal Toxin to Impair Cytokine Secretion during Infection of Dendritic Cells
J. Immunol., April 15, 2005; 174(8): 4934 - 4941.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. H. Bergman, K. D. Passalacqua, R. Gaspard, L. M. Shetron-Rama, J. Quackenbush, and P. C. Hanna
Murine Macrophage Transcriptional Responses to Bacillus anthracis Infection and Intoxication
Infect. Immun., February 1, 2005; 73(2): 1069 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. K. Pickering, M. Osorio, G. M. Lee, V. K. Grippe, M. Bray, and T. J. Merkel
Cytokine Response to Infection with Bacillus anthracis Spores
Infect. Immun., November 1, 2004; 72(11): 6382 - 6389.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. T. Young and A. Dillin
MAPping innate immunity
PNAS, August 31, 2004; 101(35): 12781 - 12782.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.